| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oncology Institute, Inc. | Chief Financial Officer | Common Stock | 474,931 | $1,006,854 | $2.12 | 21 May 2024 | Direct |
| Oncology Institute, Inc. | Chief Financial Officer | Non-Qualified Stock Option (right to buy) | 378,648 | 21 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TOI | Oncology Institute, Inc. | 21 May 2024 | 2 | $0 | 4 | Chief Financial Officer | 23 May 2024, 18:33 |
| TOI | Oncology Institute, Inc. | 14 Dec 2023 | 2 | +$126,989 | 4 | Chief Financial Officer | 18 Dec 2023, 15:26 |
| TOI | Oncology Institute, Inc. | 23 May 2023 | 2 | -$1,473 | 4 | Chief Financial Officer | 24 May 2023, 20:43 |
| TOI | Oncology Institute, Inc. | 17 Mar 2023 | 2 | $0 | 4 | Chief Financial Officer | 21 Mar 2023, 21:00 |
| TOI | Oncology Institute, Inc. | 17 Nov 2022 | 2 | $0 | 4 | Chief Financial Officer | 21 Nov 2022, 16:35 |
| TOI | Oncology Institute, Inc. | 19 May 2022 | 2 | $0 | 4 | Chief Financial Officer | 19 May 2022, 18:43 |
| TOI | Oncology Institute, Inc. | 04 Apr 2022 | 0 | $0 | 3 | Chief Financial Officer, Principal Financial Officer | 05 Apr 2022, 17:43 |